Kevin Schwartz

Adjunct Scientist (Full Status)

ICES Affiliation

ICES UofT
Populations & Public Health Research Program

Phone
647-260-7629

Biography

Contact Kevin Schwartz

@kevin_kls

Education

Diploma in Tropical Medicine and Hygiene, The Gorgas Course of Tropical Medicine
FRCPC, Infectious Diseases, University of Toronto
FRCPC, Pediatrics, University of Calgary
MSc, Clinical Epidemiology, University of Toronto
MD, University of Toronto

Research Focus

Drug prescribing behaviour
Infectious diseases

Other Affiliations

Infection Prevention and Control (IPAC) and Antimicrobial Stewardship Physician, Public Health Ontario
Assistant Professor, Dalla Lana School of Public Health, University of Toronto
Infectious Disease Consultant, St. Joseph's Health Centre

Recent ICES Grants

The prevention of group B streptococcal (GBS) disease in infants

Principal investigators: Crowcroft N, Fell D, Sander B
Co-investigators: Barrett J, Bolotin S, Brown KA, Fittipaldi NV, Mcgeer AJ, Murti M, Sadarangani M, Schwartz KL, Wilson K
Canadian Institutes of Health Research, Project Grant
2019-2022; $409,276
Comprehensive Ontario Microbiology laBoratory Administrative daTa for AntiMicrobial Resistance (COMBAT-AMR)

Principal investigators: Brown KA, Daneman N
Co-investigators: Sander B, Schwartz KL, Stukel T
Canadian Institutes of Health Research, Project Scheme Grant
2018-2021; $608,176
Influenza vaccines, statins, and laboratory-confirmed influenza outcomes in older adults: can vaccines and statins reduce the burden of influenza?

Principal investigator: Kwong J
Co-investigators: Buchan S, Campitelli M, Rosella L, Schwartz K
Canadian Institutes of Health Research, Project Scheme Grant
2018-2020; $202,725

Recent ICES Publications

8/23/2021

Exploring the reasons for low pertussis vaccine effectiveness in Ontario, Canada, 2006-2008: a Canadian Immunization Research Network study

Hughes SL, Kwong JC, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Mahmud SM, Crowcroft NS. Can J Public Health. 2021; Aug 23 [Epub ahead of print]. DOI: https://doi.org/10.17269/s41997-021-00536-1

8/20/2021

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. BMJ. 2021; 374:n1943. Epub 2021 Aug 20. DOI: doi: https://doi.org/10.1136/bmj.n1943

6/17/2021

Duration of SARS-CoV-2 shedding: a population-based, Canadian study

Phillips SP, Wei X, Kwong JC, Gubbay J, Schwartz KL, Majury A, Groome PA. PLoS One. 2021; 16(6):e0252217. Epub 2021 Jun 17. DOI: https://doi.org/10.1371/journal.pone.0252217

See more ICES Publications

News coverage

Healthline.com12/10/2018Article